Enzyme&Related Buffer for mRNA
Nucleotides for mRNA
Cap Analogs
Stock mRNA
Kits for mRNA
LNP
Phosphoramidites
Nucleosides
GalNAc
Enzymatic Oligo Synthesis
Succinates
Phosphorus Reagent
Nucleotides for Diagnostics
DNA Phosphoramidites
2'-O-TBDMS Phosphoramidites
2'-O-Me Phosphoramidites
2'-Fluoro Phosphoramidites
2'-O-MOE Phosphoramidites
2'-O-4'-C-Locked Phosphoramidites
2'-O-propargyl Phosphoramidites
UNA Phosphoramidites
cEt Phosphoramidites
2'-O-NMA Phosphoramidites
VP Phosphoramidites
TNA Phosphoramidites
Reverse Phosphoramidites
GNA Phosphoramidites
SNA Phosphoramidites
PMO Phosphoramidites
2'-O-Bn Phosphoramidites
2'-O-(TFA)amino Phosphoramidites
2'-O-4'-C-ethylene Phosphoramidites
Thiophosphoramidite
Abasic Phosphoramidites
Dimer Phosphoramidites
Linker Phosphoramidites
HOMO Phosphoramidites
3'-Obutyn Phosphoramidites
3'-Amino Phosphoramidites
2'-O-Aliphatic Phosphoramidites
Arabino Phosphoramidites
3'-O-𝑖Pr Phosphoramidites
2'-O-EOE Phosphoramidites
2'-O-MOEOE Phosphoramidites
DNA Phosphoramidates
Impurity Standards
2'-F Nucleosides
2'-O-Me Nucleosides
2'-O-MOE Nucleosides
2'-O-4'-C-Locked-NA Nucleosides
RNA Nucleosides
Deoxynucleosides
Other Modified Nucleosides
Other Protected Nucleosides
2026-07-15
近日，由海军军医大学第二附属医院(上海长征医院)谢渭芬教授团队原创、上海赛迪夫医药转化的CD-GA-102注射液，正式获得美国FDA新药临床试验(IND)许可。该项目同时具备两个“全球首个”的标签:其一，全球首个基于转录因子诱导分化机制治疗肝癌的药物;其二，全球首款进入临床阶段的全身应用自复制RNA(srRNA)肿瘤治疗药物。此次获批，标志着中国在实体瘤“诱导分化”这一前沿全新赛道上取得新的突破。
本项目申基生物支持了整套mRNA合成物料，包括自主知识产权帽类似物!
